Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine

First line treatment for pancreatic cancer consists of surgical resection, if possible, and a subsequent course of chemotherapy using the nucleoside analogue gemcitabine. In some patients, an active transport mechanism allows gemcitabine to enter efficiently into the tumor cells, resulting in a sign...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Quinn, Bridget A., Wang, Si, Barile, Elisa, Das, Swadesh K., Emdad, Luni, Sarkar, Devanand, De, Surya K., Kharagh, Susan Morvaridi, Stebbins, John L., Pandol, Stephen J., Fisher, Paul B., Pellecchia, Maurizio
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941374/
https://ncbi.nlm.nih.gov/pubmed/26959746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7931
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados